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Summary
Resistance of mammalian cells to SN1-type methylat-
ing agents such as N-methyl-N-nitro-N-nitrosogua-
nidine (MNNG) generally arises through increased ex-
pression of methylguanine methyltransferase (MGMT),
which reverts the cytotoxic O6-methylguanine (MeG) to
guanine, or through inactivation of the mismatch re-
pair (MMR) system, which triggers cell death through
aberrant processing of MeG/T mispairs generated dur-
ing DNA replication when MGMT capacity is exceeded
[1]. Given that MMR and MeG-detoxifying proteins are
functionally conserved through evolution, and that
MMR-deficient Escherichia coli dam− strains are also
resistant to MNNG [2], the finding that MMR status did
not affect the sensitivity of Saccharomyces cerevis-
iae to MNNG [3] was unexpected. Because MeG resi-
dues in DNA trigger homologous recombination (HR)
[4–7], we wondered whether the efficient HR in S. cere-
visiae might alleviate the cytotoxic effects of MeG pro-
cessing. We now show that HR inactivation sensitizes
S. cerevisiae to MNNG and that, as in human cells,
defects in the MMR genes MLH1 and MSH2 rescue
this sensitivity. Inactivation of the EXO1 gene, which
encodes the only exonuclease implicated in MMR to
date [8, 9], failed to rescue the hypersensitivity, which
implies that scExo1 is not involved in the processing
of MeG residues by the S. cerevisiae MMR system.
Results and Discussion
In the yeast Saccharomyces cerevisiae, the functional
homolog of human MGMT, scMgt1p, has been shown
to remove methyl groups from MeG residues and, to a
lesser extent, from O4-methylthymine [10], and to pro-
tect the cells from both mutagenesis and killing in-
duced by MNNG [3]. The key players in postreplicative
MMR are the MutS homologs scMsh2p, scMsh3p, and
scMsh6p and the MutL homologs scMlh1p and scPms1p
(functional homolog of the human PMS2). These poly-
peptides are also functionally highly related to the hu-
man proteins, yet the MMR status of S. cerevisiae was
reported not to influence the response of mgt1 mutants
to methylating agents [3]. This difference between the
lower and higher eukaryotic cells is unlikely to be due
to the lack of apoptosis in yeast because mammalian*Correspondence: jiricny@imcr.unizh.ch
2 Present address: Center for Biomedical and Clinical Sciences,
University of Basel, Mattenstrasse 28, CH-4058 Basel, Switzerland.cells can be efficiently killed by MNNG without having
to activate the machinery of programmed cell death
[11] and because even dam− MMR-deficient E. coli are
more resistant to killing by this methylating agent than
MMR-proficient strains [2]. We therefore reasoned that
the different response of yeast and mammalian cells to
methylating agents might be explained either by differ-
ences in DNA-damage recognition or else by differ-
ences in other pathways of methylation-damage pro-
cessing.
The human mismatch binding factor hMSH2/hMSH6
(hMutSα) has been reported to bind oligonucleotide
substrates containing MeG/T or MeG/C mispairs [12],
and we wanted to test whether the yeast proteins be-
haved similarly. To this end, we overexpressed the
S. cerevisiae MMR-recognition factor scMsh2p/scMsh6p
(scMutSα) and purified it to near homogeneity (Fig-
ure 1A). Gel-shift assays with increasing amounts of
scMutSα (1.7–67 nM) and a constant amount (6.6 nM)
of MeG/T-, MeG/C-, G/T- and G/C-containing oligonucle-
otide duplexes (Figures 1B–1E) revealed that all DNA
substrates formed slowly migrating protein/DNA com-
plexes at high (>30 nM) scMutSα concentrations. For-
mation of these nonspecific (ns) complexes has been
observed previously [13] and probably results from ag-
gregation of scMsh2p/scMsh6p heterodimers on the
same oligonucleotide substrate. In contrast, the MeG/T
and G/T substrates formed a more rapidly migrating
specific (s) complex with the heterodimer; this complex
already appeared at low protein concentrations and
represented w90% of the total labeled oligonucleotide
duplex at 16.4 nM protein concentration (lane with an
asterisk in Figures 1B and 1C). In case of the MeG/C
substrate, only a small amount of the specific complex
was formed at lower protein concentrations (w35% at
16.4 nM scMutSα, Figure 2E, lane with an asterisk), but
this amount was higher than that formed by the G/C
homoduplex substrate (w10%, see Figure 2D, lane with
an asterisk). In both latter cases, the nonspecific band
was also apparent at the 16.4 nM scMutSα concentra-
tion, indicating a weak recognition of the MeG/C sub-
strate. These results were confirmed in competition as-
says, in which the labeled G/T heteroduplex (6.6 nM) in
the presence of scMutSα (16.4 nM) was competed with
a 10-fold excess of the unlabeled MeG/T, MeG/C, G/T, or
G/C duplexes. In these experiments, the MeG/T oligo-
nucleotide appeared to be an even better substrate
for scMutSα than G/T (Figure 1F), although it should
be pointed out that the affinity of the mismatch bind-
ing heterodimer for the methylated oligonucleotides is
highly dependent on sequence context, which is gen-
erally not the case for G/T (our unpublished observa-
tions). Differences in DNA-damage recognition thus
cannot explain the difference in phenotype between
yeast and mammalian cells. We therefore argued that
these differences must lie in the processing of methyla-
tion damage downstream from damage recognition.
Treatment of mammalian and yeast cells with MNNG
was reported to give rise to elevated levels of homolo-
gous recombination (HR). Furthermore, in human cells,
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Figure 1. Substrate Specificity of the S. cerevisiae Mismatch Bind- n
ing Factor Msh2p/Msh6p p
(A) Overexpression of scMsh2p/Msh6p in E. coli. Uninduced, total o
extract from BL21 codon plus cells; Induced, total extract from t
BL21 codon plus cells overexpressing scMsh2p/Msh6p; SP, Hepa- q
rin and Mono Q, pooled fractions eluted from the respective FPLC sxamine the involvement of the EXO1 gene, which en-
hromatography columns. The figure shows aliquots from different
urification steps separated on a denaturing 7.5% polyacrylamide
el stained with Coomassie Blue.
B–E) Binding of the scMsh2p/Msh6p heterodimer to different DNA
ubstrates. Formation of specific (s) and nonspecific (ns) complexes.
he heterodimer (1.7–67 nM) was incubated with 32P-labeled 6.6 nM
/T, MeG/T, G/C, or MeG/C DNA substrates. The lane with 16.4 nM
rotein concentration is indicated by an asterisk. The protein/DNA
omplexes were analyzed by a gel-shift assay as described in the
xperimental Procedures and visualized by autoradiography. (E)
ompetition binding assay. The Msh6p/Msh2p heterodimer (16.4
M) was incubated with 6.6 nM 32P-labeled G/T heteroduplex. The
reformed complexes were then challenged with a 10-fold excess
f unlabeled G/T, MeG/T, G/C, and MeG/C DNA substrates. The frac-
ion of the labeled G/T substrate bound by Msh2p/Msh6p was
uantitated by Typhoon 9600 PhosphoImager with ImageQuant
oftware.R was elevated specifically in an MMR-dependent
anner [4–7]. Given that the efficiency of HR in S. cere-
isiae is substantially higher than in mammalian cells,
e wondered whether this could be the underlying
ause of the different responses of these organisms to
ethylating agents. Inactivation of the RAD52 gene,
hich is required for most HR processes in S. cerevis-
ae, rendered the cells hypersensitive to MNNG. Addi-
ional inactivation of the MMR genes MSH2 or MLH1
ad no effect on sensitivity, which was not particularly
urprising given that these cells expressed scMgt1p
Figure 2A). However, when the MGT1 gene was also
nactivated, the mgt1 rad52 double mutant became ex-
uisitely sensitive to MNNG, whereas the mgt1 rad52
sh2 and mgt1 rad52 mlh1 triple mutants were sensi-
ized to a substantially lesser extent (Figure 2B). It
herefore appears that MMR-mediated processing of
eG residues gives rise to cytotoxic intermediates that
re resolved by homologous recombination. Due to the
igh efficiency of HR in yeast, these intermediates are
ost likely successfully repaired, which would account
or the substantial resistance of MMR-proficient yeast
ells to MNNG. Interestingly, the survival curve of the
gt1 rad52 strain appears to be biphasic (Figure 2B).
t low MNNG concentrations (0.5–1.5 M), the inactiva-
ion of MSH2 or MLH1 fully suppresses the sensitivity
f the mgt1 rad52 strain to MNNG, which shows that
he killing is at this concentration range linked almost
xclusively to the processing of MeG residues by the
MR system. In contrast, cell death at high MNNG
oncentrations (>3 M) is also most likely caused by
ther types of damage, such as strand breaks arising
hrough processing of N-methylated purines and aba-
ic sites, which account for more than 90% of the dam-
ge caused by these agents. Moreover, overexpression
f scMgt1p in the rad52 strain failed to improve survival
t high MNNG concentrations (data not shown), which
urther supports the hypothesis that the cytotoxicity is
n this case linked to DNA modifications distinct from
eG. A similar situation was also observed in human
ells [14].
It is well established that both scMsh2p and scMlh1p
re absolutely required for MMR, whereas the mecha-
ism and players in the downstream events of the re-
air process remain enigmatic. We thus decided to
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1397Figure 2. MNNG-Induced Killing of S. cere-
visiae Strains with Different Genetic Back-
grounds
(A) Comparison of MNNG sensitivities of the
MMR-deficient (mlh1 or msh2) and/or recom-
bination-deficient (rad52) strains as mea-
sured by the spot test. Mid-log phase cells
were treated with the indicated concentra-
tions of MNNG, harvested and spotted on
YPD plates at proper serial dilutions as de-
scribed in the Experimental Procedures.
(Wild-type genes are labeled with capitals,
deletion mutants with lowercase letters)
Sensitivity to ultraviolet (UV) light was used
as a control. The upper panel shows a repre-
sentative experiment, and the lower panel
shows a graphic representation of data pooled
from 3–5 independent experiments. Error bars
show standard error of the mean.
(B) Effect of methylguanine methyltransfer-
ase (mgt1) deficiency on the sensitivity of
MMR- and/or recombination-deficient strains
to MNNG. Sensitivity to UV light was used as
a control. The upper panel shows a repre-
sentative experiment, and the lower panel
shows a graphic representation of data
pooled from 3–5 independent experiments.
Error bars show standard error of the mean.codes the only exonuclease implicated in MMR to date
(with the notable exception of the proofreading activity
of polymerase delta [8, 15]) in the processing of methyl-
ation damage induced by MNNG. In contrast to MSH2
and MLH1 inactivation, which rescued the hypersensi-
tive phenotype of the mgt1 rad52 mutant strain, dele-
tion of the EXO1 gene brought about a further, albeit
minor, increase in MNNG sensitivity (Figure 3). These
results suggest that scExo1p helps the cell overcome
the deleterious effects of DNA methylation, rather than
being involved in the MMR-dependent cytotoxic pro-
cessing of MeG residues. The role of the scExo1p in
MMR has been the subject of some discussion. The
protein plays a role in several other biological pro-cesses, including mutation-avoidance pathways dis-
tinct from MMR, telomere integrity, and processing of
double-strand breaks prior to homologous recombina-
tion, and it is likely that its functions overlap with those
of other exonucleases [16]. Although our data provide
evidence that scExo1p is not required for the process-
ing of methylation damage, they fail to indicate which
exonuclease (if any) fulfills this role in vivo.
The interaction between yeast MMR and HR in the
processing of DNA damage has been described pre-
viously [17]. In that study, disruption of MMR genes
conferred a mild but significant (1.5- to 6-fold) resis-
tance to cisplatin, carboplatin, and doxorubicin, and
contrary to our results, the resistant phenotype was de-
Current Biology
1398Figure 3. MNNG Sensitivities of Recombina-
tion- (rad52), Methylguanine Methyltransfer-
ase- (mgt1), and/or Exonuclease 1 (exo1)-Defi-
cient S. cerevisiae
Mid-log phase cells of the indicated strains
were treated with the indicated concentra-
tions of MNNG and spotted at proper serial
dilutions on YPD plates as described in the
Experimental Procedures. The upper panel
shows a representative experiment, and the
lower panel shows a graphic representation
of data pooled from 3–5 independent experi-
ments. Error bars show standard error of the
mean.pendent on functional scRad52p. This difference can 2
tbe explained. DNA lesions induced by the above agents
block DNA replication and require recombination for ef- t
lficient lesion bypass [17]. Because MMR controls the
fidelity of recombination processes, it most likely lowers m
trecombination frequency in DNA containing these bulky
adducts and thus augments cytotoxicity. In contrast, a
hMeG/C pairs arising in methylguanine-methyltransfer-
ase-deficient cells upon methylation do not block DNA h
zsynthesis per se and are well tolerated in the absence
of MMR. Our model for the cytotoxicity of SN1-type t
amethylating agents is outlined in Figure 4. In the ab-
sence of MMR, DNA replication will give rise to one t
runmodified progeny DNA molecule and one that carries
the MeG residue paired either with thymine of cytosine, p
neither of which needs to be resolved by recombina-
Etion. In the presence of MMR, the MeG/C or MeG/T mis-
pairs arising during replication are detected by the
P
scMsh2/scMsh6 heterodimer, which triggers a round of T
repair. However, because MMR is directed to the newly w
synthesized DNA strand, the modified nucleotide per- i
[sists in the template strand. Because the polymerase
filling the repair patch cannot find a perfect base-pair-
Oing partner for MeG, it may leave a gap or a similar
Tlesion that could be repaired by HR. In the absence of
A
HR, the gap would be converted during the next repli- C
cation round to a double-strand break that might trig- G
Cger cell-cycle arrest and cell death.
lIn summary, we show that damage reversal by
oscMgt1p, along with methylation damage processing
tand repair by HR, mask the sensitivity of MMR-profi-
t
cient S. cerevisiae cells toward killing by SN1-type o
methylating agents. Inactivation of MMR in the mgt1 m
trad52 yeast background rendered cells approximately0-fold more tolerant to killing by MNNG Recombina-
ion-deficient S. cerevisiae thus resemble the methyla-
ion-sensitive phenotype of mammalian cells [18]. The
ack of involvement of scExo1p in the processing of
ethylation damage implies that the exonuclease func-
ion is fulfilled by another enzyme(s). Given the amen-
bility of S. cerevisiae to genetic manipulation and
igh-throughput screening, our present results should
elp us design assays for identification of these en-
ymes, as well as of other gene products involved in
he processing of methylation damage. It is hoped that
t least some of these findings will help us understand
he mode of action of SN1 methylating agents, which
epresent an important class of cancer chemothera-
eutics.
xperimental Procedures
roduction of scMsh2-scMsh6 in E. coli
he pET11a-scMSH2-scMSH6 plasmid (a kind gift of M. Hingorani)
as transformed into BL21 DE3 codon plus cells (Strategene). The
nduction and purification was performed essentially as described
19], except that ultrasonic treatment was used for cell disruption.
ligonucleotide Substrates
he 34-mers 34TopG (AATTCCCGGGGATCCGTCGACCTGCAGCC
AGCT), 34TopMeG (AATTCCCGGGGATCCGTCMeGACCTGCAGC
AAGCT), 34BottomT (AGCTTGGCTGCAGGTTGACGGATCCCCG
GAATT) and 34BottomC (AGCTTGGCTGCAGGTCGACGGATCC
CGGGAATT) were synthesized by Microsynth (Balgach, Switzer-
and) and purified by polyacrylamide gel electrophoresis (the sites
f mismatch or base modification are underlined). Despite the fact
hat Microsynth strictly adhered to the protocol for MeG incorpora-
ion into the oligonucleotide, as recommended by the manufacturer
f the corresponding phosphoramidite (Glenn Research, USA),
ass-spectrometric analysis by NanoESI revealed that a substan-
ial part of the MeG-containing oligonucleotide still contained the
Methylation Tolerance and MMR in Yeast
1399Figure 4. Model of MMR-Induced Killing
upon Treatment with Methylating Agents
See text for details.8.0]) and 6.6 nM of the labeled substrate in binding buffer (10% FF18733 and FF18734 S. cerevisiae strains (a kind gift of F. Fabre)
Table 1. S. cerevisiae Strains Used in This Study
Strain Relevant Genotype Source
FF18733 MATa; leu2-3, 112; ura3-52; his7-2; lys1-1, trp1-289 F. Fabre
ZS30 FF18733 with msh2::KANMX Z. Storchova
EP82 FF18733 with mlh1::KANMX E. Papouli
FPC 45 FF18733 with rad52::URA3 this study
FPC 1-1 FF18733 with mgt1::KANMX this study
FPC 50 FF18733 with exo1::KANMX this study
FPC 32 FF18733 with mgt1::KANMX; rad52::URA3 this study
FPC 24 FF18733 with rad52::URA3; msh2::KANMX this study
FPC 37 FF18733 with rad52::URA3; mlh1::KANMX this study
FPC 3-3b FF18733 with mgt1::KANMX; msh2::KANMX this study
FPC15 FF18733 with mgt1::KANMX; mlh1::KANMX this study
FPC 52 FF18733 with rad52::URA3; exo1::KANMX this study
FPC 55 FF18733 with mgt1::KANMX; exo1::KANMX this study
FPC 21 FF18733 with mgt1::KANMX; rad52::URA3; msh2::KANMX this study
FPC 61 FF18733 with mgt1::KANMX; rad52::URA3; exo1::KANMX this study
FPC 39 FF18733 with mgt1::KANMX; rad52::URA3; mlh1::KANMX this study
FF18734 MATα; leu2-3, 112; ura3-52; his7-2; lys1-1, trp1-289 F. Fabre
ZS30-1d FF18734 with msh2::KANMX this study
EP 85 FF18734 with mlh1::KANMX E. Papouli
FF18743 FF18734 with rad52::URA3 F. Fabre
FPC 2-1 FF18734 with mgt1::KANMX this study
FPC 51 FF18734 with exo1::KANMX this study
FPC 30 FF18734 with mgt1::KANMX; rad52::URA3 this study
FPC 28 FF18734 with rad52::URA3; msh2::KANMX this study
EP 95 FF18734 with rad52::URA3; mlh1::KANMX E. Papouli
FPC 3-2a FF18734 with mgt1::KANMX; msh2::KANMX this study
FPC 16 FF18734 with mgt1::KANMX; mlh1::KANMX this study
FPC 54 FF18734 with rad52::URA3; exo1::KANMX this study
FPC 58 FF18734 with mgt1::KANMX; exo1::KANMX this study
FPC 22 FF18734 with mgt1::KANMX; rad52::URA3; msh2::KANMX this study
FPC 59 FF18734 with mgt1::KANMX; rad52::URA3; exo1::KANMX this study
FPC 43 FF18734 with mgt1::KANMX; rad52::URA3; mlh1::KANMX this studyisobutyryl protecting group on the exocyclic nitrogen of the methyl-
ated guanine. The fully deprotected oligonucleotide had to be sep-
arated from the contaminant by reverse-phase HPLC, for which a
Nucleosil 100Å, C18, 5 m, 250 × 4.0 mm column (BGB Analytik)
eluted with a linear gradient of 5%–20% acetonitrile in 100 mM
triethylamonium acetate (pH 7) was used. The “bottom” oligonucle-
otides were radioactively labeled with [γ-32P]-ATP (Amersham Bio-
sciences) and polynucleotide kinase (New England Biolabs) and
purified on Sephadex G25 columns. Three pmol of the labeled
“bottom” oligonucleotides were then annealed with 4.5 pmol of the
cold top oligonucleotides in 1× polynucleotide kinase buffer by
brief heating to 95°C and slow cooling to room temperature. In
this way we obtained the duplex substrates G/C, G/T, MeG/C, and
MeG /T.
Gel-Shift Experiments
The indicated amounts of purified S. cerevisiae Msh2p/Msh6p pro-
tein (diluted where necessary in 50 mM NaCl, 25 mM Tris.HCl [pHglycerol, 0.33 mg/ml BSA, 25 mM HEPES [pH 8.0], 0.5 mM EDTA,
and 0.5 mM DTT) were incubated for 20 min at room temperature
in a total volume of 30 l. The reaction products were separated
on 6% polyacrylamide gels (acrylamide:bisacrylamide ratio 19:1) at
room temperature at 150V for 85 min. The gels were dried and
scanned with the Typhoon 9400 imager and ImageQuant TL soft-
ware (both Amersham Biosciences).
Yeast Media
For unselective growth, YPD medium (2% glucose, 2% bactopep-
tone, and 1% yeast extract) was used. Clones where the gene of
interest was replaced by the KANMX cassette were selected on
YPD plates supplemented with 200 g/ml G418 (Invitrogen). Where
necessary, the media were solidified by 2% agar (Difco). All yeast
strains were propagated under aerobic conditions at 30°C.
Yeast Strains and Transformation
The yeast strains used in this study were all isogenic derivatives of
Current Biology
1400and are listed in Table 1. Replacement of the MMR genes was per-
formed with kanMX4 replacement cassettes with specifically de-
signed primers (see below), with pUG6 (MSH2, MGT1, and EXO1)
or pFA6a-kanMX4 (MLH1) plasmids being used as templates for
polymerase chain reactions (PCR), essentially as described [20].
The primer sequences for gene disruption were as follows (forward,
reverse primer):
MSH2, GACACTCTACTCCAATATCAACTGTAAAAAATCTCTTTAT
CTGCTGGACCTAACATCAAAATCCTCAGATTAAAAGGAGCTGA
AGCTTCGTACGC, CTTTCCAATGCATATTATATGTACTATTTGTA
TCTATATATTATCTATCGATTCTCACTTAAGATGTCGTTGTAATAT
TAATTATAACAACGCATAGGCCACTAGTGGATCTG;
MLH1, ATAGTGATAGTAAATGGAAGGTAAAAATAACATAGACCTA
TCAATAAGCACAGCTGAAGCTTCGTACGC, AAAGGAAAGGGC
ATACACTTTCAAATGAAACACAATCACACTCAGGAAATGCATA
GGCCACTAGTGGATCTG;
MGT1, TGGCAGGGCATTTAAAATGCGGTGGAAACAAGGAAGAT
TAATCAAGTAATGATATAGCATCAGCTGAAGCTTCGTACGCTGC
AG, CAATTTACCACATATACATAACTATTTCTTATGTTTATTTTCC
TAAAATCCTTTATCCAAGCATAGGCCACTAGTGGATCTG;
EXO1, TGCTTTTTGGACCACATTAAAATAAAAGGAGCTCGAAAAA
ACTGAAAGGCGTAGAAAGGACAGCTGAAGCTTCGTACGCTG
CAG,TTCGACGAGATTTTCATTTGAAAAATATACCTCCGATATG
AAACGTGCAGTACTTAACTTGCATAGGCCACTAGTGGATCTG.
The transformations were performed by the lithium-acetate
method. The genotypes of all strains used were verified by PCR
(primer sequences and details are available on request), Southern
blotting, and tetrad analysis.
1Spot Tests
A stock solution of 1 M MNNG (Sigma) was prepared in DMSO and
stored in the dark at −20°C. Because of the estimated w45 min
half-life of MNNG in aqueous solutions, all experiments were per-
1formed in liquid cultures as follows: The cells were inoculated from
a YPD plate into 3 ml of liquid YPD medium and cultivated over-
night. The cells were then diluted 1:15 with YPD, and 3 ml cultures
were incubated for a further 3 hr, when the cells were again in an
1exponential growth phase. The cells were then mock-treated and
treated with several concentrations of freshly diluted MNNG for 45
min. They were harvested, washed, and spotted (w12 l drops) at
serial dilutions on YPD plates. For UV treatments, the cells from
the untreated cultures were spotted at similar dilutions on several
1
YPD plates and subsequently irradiated with the indicated doses
(UV Stratalinker 1800). The plates were evaluated after 3 days of
cultivation at 30°C. Because no significant differences were ob-
served between the a and α mating types, the results shown are 1
based on 3–5 independent experiments carried out with strains in
both a and α backgrounds.
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